Both in Pharmaceuticals
Evommune vs CAMP4 Therapeutics
Over the past year EVMN returned −66.7% and CAMP returned −11.0%; their daily moves had a correlation of 0.05.
EVMN −66.7% CAMP −11.0%Growth of $1, one year, split-adjusted
| Metric | EVMN | CAMP |
|---|---|---|
| Price | $6.73 | $3.96 |
| Market cap | $244.2M | $248.5M |
| Today | −1.17% | +1.54% |
| 1 month | −6.7% | +3.1% |
| 6 months | −72.5% | −2.2% |
| Year to date | −60.7% | −35.4% |
| 1 year | — | +2.6% |
| Revenue growth (YoY) | — | +18.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1884.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 58.9× |
| Net cash | $200.4M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 85.7% | 84.1% |
| Short % of float | 16.5% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).